STRATEGY: Stick with Epicenter in 2H2021. Strong markets stay strong. US COVID-19 deaths are “unvaccinated” Americans COVID-19 cases could be rising, in part due to the spread of the more transmissible variants (Delta, etc.), but the approved vaccines seem to be containing the spread, and more importantly, limiting the severity of the disease (for a vaccinated individual). The AP published…
Energy positive returns 6 consecutive months. Stick with Epicenter in 2H2021.
A financial market resource for the every-day investor and trader.
-
-
Forward Discounting Finds Value-Seeking Opportunity
Seth Golden, , Research Reports, 0
The great Q1 2022 earnings have proven the forward-looking nature of markets. I’m kicking-off this weekend’s Research Report with...
-
Breadth, Headlines, Trade, Earnings…All Improving?
Seth Golden, , Research Reports, 0
Coming into the trading week that was, the S&P 500 (SPX) completed two up weeks in a row, and...
-
Some Light At The End Of The Tunnel For Target And J.C. Penney
Seth Golden, , Research Reports, 0
Retail sales have been a disappointment now for three consecutive months and as such this may lead to downward...
-
Is A Storm About To Hit Markets? Have an Umbrella?
Seth Golden, , Research Reports, 0
If you were asked to do nothing as an investor for the week to come, could you do it?...
-
Weekly State of the Market: Balancing Out
Seth Golden, , Research Reports, 0
To achieve long-term success over many financial market and economic cycles, observing a few rules is not enough. Too...
-
Short-Termisms: Best Remedy for Shutdown and Tapering, Is A Shutdown and Tapering
Seth Golden, , Research Reports, 0
Scary prescient, scary! I’m referring to what our chief market strategist Seth Golden wrote in last week’s Research Report....
-
Weekly State of the Market: Has Nasdaq Found It’s Base?
Seth Golden, , Research Reports, 0
Welcome to this week’s State of the Markets. Please click the following link to review this week’s SOTM. In this week’s episode, we record live on...
Recent Articles
Featured Products
- JPM Market Recap $0.00
- JPM Research Note $0.00
- JP Morgan Market Volatility Report $0.00